Primary Care

Clinic IQ is an intelligent tool that is used in GP Surgeries to provide treatment management for chronic diseases. Clinic IQ is working in the background while GPs are using their EMR system. It automatically pulls patient information, uses it to search and evaluate multiple NICE and other relevant Guidelines, and produces comprehensive patient specific recommendations for clinicians to review and enact. Effortless, non-intrusive, and no additional forms or paperwork.

Meet Clinic IQ

Clinic IQ features

Clinic IQ produces treatment management recommendations including:

  • Case finding criteria
  • Diagnostic and treatment suggestions
  • Monitoring advice
  • Referral advice
  • Clinical prompts
  • Patient education advice and materials
  • Potential QOF indicator non-compliance warnings and suggested remedial actions to ensure future QOF compliance at time of QOF checks.

Benefits

  • Accurate decision support: reducing cognitive load and aiding decision-making.
  • Compliant and defensible: auditable, defensible treatment advice, ensuring transparency and QOF compliance.
  • Improved patient outcomes: early detection, prevention and prompt evidence based treatment.
  • Cost and resource efficiencies:
    • Automating routine tasks.
    • Avoiding unnecessary tests and referrals.
    • Left shift supporting nurses, PAs & pharmacists to run clinics, reducing pressure on GPs

Frequently Asked Questions

What pathways (diseases) does Clinic IQ support?

Clinic IQ’s first Pathways Package is “Cardiometabolic Diseases”, which includes the following pathways:

  • Lipid optimisation
  • Hypertension management
  • Heart failure
  • Diabetes
  • Obesity
  • Familial hyperlipidemia
  • Diabetic foot
  • Diabetic retinopathy
  • Chronic kidney disease
  • Peripheral arterial disease.

The complete package is under development. The lipid optimisation pathway is available now, with the hypertension pathway in the final testing stages and scheduled to become available in December 2024.

The remainder of the pathways will be launched throughout 2025.

What does the lipid optimisation pathway cover?

Cardiovascular disease is the leading cause of morbidity, disability and health inequalities in the UK, accounting for 1 in 4 deaths. Lipid optimisation is the most cost-effective intervention for CVD prevention and the best opportunity for NHS resource and cost efficiencies.

Lipid optimisation pathway incorporates national guidance from published NICE, AAC, ESC & Lifespan guidelines. The pathway covers recommendations for primary and secondary prevention of cardiovascular diseases and criteria for case finding for familial hypercholesterolemia. Customisation/localisation of the pathway at PCN level using locally approved guidance is available.